6.
Kreimer A, Pierce Campbell C, Lin H, Fulp W, Papenfuss M, Abrahamsen M
. Incidence and clearance of oral human papillomavirus infection in men: the HIM cohort study. Lancet. 2013; 382(9895):877-87.
PMC: 3904652.
DOI: 10.1016/S0140-6736(13)60809-0.
View
7.
Kurita T, Chitose S, Sato K, Sakazaki T, Fukahori M, Sueyoshi S
. Pathological mechanisms of laryngeal papillomatosis based on laryngeal epithelial characteristics. Laryngoscope Investig Otolaryngol. 2019; 4(1):89-94.
PMC: 6383308.
DOI: 10.1002/lio2.242.
View
8.
Torrente M, Rodrigo J, Haigentz Jr M, Dikkers F, Rinaldo A, Takes R
. Human papillomavirus infections in laryngeal cancer. Head Neck. 2010; 33(4):581-6.
DOI: 10.1002/hed.21421.
View
9.
Gillison M, Broutian T, Pickard R, Tong Z, Xiao W, Kahle L
. Prevalence of oral HPV infection in the United States, 2009-2010. JAMA. 2012; 307(7):693-703.
PMC: 5790188.
DOI: 10.1001/jama.2012.101.
View
10.
Fortes H, von Ranke F, Escuissato D, Araujo Neto C, Zanetti G, Hochhegger B
. Recurrent respiratory papillomatosis: A state-of-the-art review. Respir Med. 2017; 126:116-121.
DOI: 10.1016/j.rmed.2017.03.030.
View
11.
Ahn D, Heo S, Lee G, Sohn J, Jeong J
. Prevalence and characteristics of tonsillar human papillomavirus infection in tumor-free patients undergoing tonsillectomy. Auris Nasus Larynx. 2021; 49(2):229-234.
DOI: 10.1016/j.anl.2021.07.011.
View
12.
Wierzbicka M, Klussmann J, San Giorgi M, Wuerdemann N, Dikkers F
. Oral and laryngeal HPV infection: Incidence, prevalence and risk factors, with special regard to concurrent infection in head, neck and genitals. Vaccine. 2021; 39(17):2344-2350.
DOI: 10.1016/j.vaccine.2021.03.047.
View
13.
You E, Henry M, Zeitouni A
. Human papillomavirus-associated oropharyngeal cancer: review of current evidence and management. Curr Oncol. 2019; 26(2):119-123.
PMC: 6476447.
DOI: 10.3747/co.26.4819.
View
14.
Hirai R, Makiyama K, Higuti Y, Ikeda A, Miura M, Hasegawa H
. Pharyngeal squamous cell papilloma in adult Japanese: comparison with laryngeal papilloma in clinical manifestations and HPV infection. Eur Arch Otorhinolaryngol. 2012; 269(10):2271-6.
DOI: 10.1007/s00405-011-1908-0.
View
15.
Mehanna H, Taberna M, von Buchwald C, Tous S, Brooks J, Mena M
. Prognostic implications of p16 and HPV discordance in oropharyngeal cancer (HNCIG-EPIC-OPC): a multicentre, multinational, individual patient data analysis. Lancet Oncol. 2023; 24(3):239-251.
DOI: 10.1016/S1470-2045(23)00013-X.
View
16.
Gheit T, Muwonge R, Lucas E, Galati L, Anantharaman D, McKay-Chopin S
. Impact of HPV vaccination on HPV-related oral infections. Oral Oncol. 2022; 136:106244.
PMC: 9833124.
DOI: 10.1016/j.oraloncology.2022.106244.
View
17.
Omland T, Lie K, Akre H, Sandlie L, Jebsen P, Sandvik L
. Recurrent respiratory papillomatosis: HPV genotypes and risk of high-grade laryngeal neoplasia. PLoS One. 2014; 9(6):e99114.
PMC: 4053369.
DOI: 10.1371/journal.pone.0099114.
View
18.
CROISSANT O, Breitburd F, Orth G
. Specificity of cytopathic effect of cutaneous human papillomaviruses. Clin Dermatol. 1985; 3(4):43-55.
DOI: 10.1016/0738-081x(85)90048-3.
View
19.
Wojtera M, Paradis J, Husein M, Nichols A, Barrett J, Salvadori M
. The prevalence of human papillomavirus in pediatric tonsils: a systematic review of the literature. J Otolaryngol Head Neck Surg. 2018; 47(1):8.
PMC: 5789580.
DOI: 10.1186/s40463-018-0255-1.
View
20.
Gooi Z, Chan J, Fakhry C
. The epidemiology of the human papillomavirus related to oropharyngeal head and neck cancer. Laryngoscope. 2016; 126(4):894-900.
DOI: 10.1002/lary.25767.
View